AWA
ABBV icon

AGH Wealth Advisors’s AbbVie ABBV Stock Holding History

AGH Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$629K Sell
2,890
-37
-1% -$8.21K 0.46% 43
2025
Q4 		$669K Sell
2,927
-350
-11% -$79.7K 0.5% 38
2025
Q3 		$759K Buy
3,277
+11
+0.3% +$2.24K 0.56% 35
2025
Q2 		$606K Buy
3,266
+350
+12% +$65K 0.5% 38
2025
Q1 		$611K Buy
2,916
+13
+0.4% +$2.53K 0.59% 34
2024
Q4 		$516K Buy
+2,903
New +$534K 0.48% 47

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AGH Wealth Advisors's ABBV Position: Q1 2026 in Review

AGH Wealth Advisors reduced its AbbVie (ABBV) stake by 1.3% in Q1 2026, selling an estimated $8.21K and leaving 2,890 shares worth $629K. The position accounts for 0.46% of the portfolio, ranked #43.

AGH Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $759K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • AGH Wealth Advisors held 2,890 shares of AbbVie worth $629K as of Q1 2026.
  • AGH Wealth Advisors sold 37 AbbVie shares in Q1 2026, an estimated $8.21K.
  • AbbVie made up 0.46% of AGH Wealth Advisors's portfolio in Q1 2026, its #43 holding.
  • AGH Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • AGH Wealth Advisors's AbbVie position peaked at $759K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AGH Wealth Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.